Cargando…

Metastatic Breast Cancer Recurrence after Bone Fractures

SIMPLE SUMMARY: Bone fractures bear potential risk to promote metastatic relapse in breast cancer. We conducted a population-based cohort study of 84,300 breast cancer patients diagnosed between January 2015 and November 2019. Bone fracture after breast cancer diagnosis was associated with an increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obi, Nadia, Werner, Stefan, Thelen, Frank, Becher, Heiko, Pantel, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833729/ https://www.ncbi.nlm.nih.gov/pubmed/35158869 http://dx.doi.org/10.3390/cancers14030601

Ejemplares similares

Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort
por: Le Cornet, Charlotte, et al.
Publicado: (2023)

Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors
por: Heidrich, Isabel, et al.
Publicado: (2023)

Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort
por: Maurer, Tabea, et al.
Publicado: (2021)

Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case–control study
por: Möhl, Annika, et al.
Publicado: (2023)

Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort
por: Obi, Nadia, et al.
Publicado: (2021)

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
por: Roth, Carina, et al.
Publicado: (2010)

'Omic approaches to preventing or managing metastatic breast cancer
por: Griffith, Obi L, et al.
Publicado: (2011)

Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
por: Babayan, Anna, et al.
Publicado: (2013)

Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence
por: Knipper, Sophie, et al.
Publicado: (2021)

Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
por: Nickels, Stefan, et al.
Publicado: (2013)

The lingering mysteries of metastatic recurrence in breast cancer
por: Riggio, Alessandra I., et al.
Publicado: (2020)

Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells
por: Werner, Stefan, et al.
Publicado: (2015)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Stress in Metastatic Breast Cancer: To the Bone and Beyond
por: Lourenço, Catarina, et al.
Publicado: (2022)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients
por: Braun, Stephan, et al.
Publicado: (2001)

Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer
por: Wang, Qian, et al.
Publicado: (2019)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
por: Koch, Claudia, et al.
Publicado: (2020)

Rib fractures after reirradiation plus hyperthermia for recurrent breast cancer: Predictive factors
por: Oldenborg, Sabine, et al.
Publicado: (2016)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2007)

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)

Review of Bone Modifying Agents in Metastatic Breast Cancer
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2021)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
por: Alix-Panabières, Catherine, et al.
Publicado: (2009)

Osteoblasts are “educated” by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment
por: Kolb, Alexus D., et al.
Publicado: (2019)

Spine Metastases in Immunocompromised Mice after Intracardiac Injection of MDA-MB-231-SCP2 Breast Cancer Cells
por: Brylka, Laura, et al.
Publicado: (2022)

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Pantel, Klaus, et al.
Publicado: (2022)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2009)

Tired of feeling tired – The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors
por: Maurer, T., et al.
Publicado: (2021)

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_0snngkse6c1u2gjq0m4nkfkthn